Novo Integrated Sciences Revenue 2012-2024 | NVOS

Novo Integrated Sciences revenue from 2012 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Novo Integrated Sciences Annual Revenue
(Millions of US $)
2024 $13
2023 $13
2022 $12
2021 $9
2020 $8
2019 $9
2018 $9
2017 $8
2016 $0
2016 $7
2015 $0
2014 $0
2013 $0
2012 $0
2012 $0
2011 $0
2011 $0
Novo Integrated Sciences Quarterly Revenue
(Millions of US $)
2024-08-31 $3
2024-05-31 $3
2024-02-29 $3
2023-11-30 $4
2023-08-31 $3
2023-05-31 $3
2023-02-28 $3
2022-11-30 $3
2022-08-31 $-8
2022-05-31 $14
2022-02-28 $3
2021-11-30 $3
2021-08-31 $3
2021-05-31 $2
2021-02-28 $2
2020-11-30 $2
2020-08-31 $2
2020-05-31 $1
2020-02-29 $2
2019-11-30 $3
2019-08-31 $2
2019-05-31 $2
2019-02-28 $2
2018-11-30 $2
2018-08-31 $2
2018-05-31 $2
2018-02-28 $2
2017-11-30 $2
2017-08-31 $2
2017-05-31 $2
2017-03-31
2017-02-28 $2
2016-12-31
2016-11-30 $2
2016-09-30
2016-06-30
2016-05-31 $2
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-08-31
2012-06-30
2012-03-31
2012-02-29
2011-12-31
2011-11-30
2011-09-30
2011-08-31
2011-06-30
2011-05-31
2011-03-31
2011-02-28
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.000B $0.013B
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.031B 19.74
Encompass Health (EHC) United States $12.013B 25.47
DaVita (DVA) United States $10.339B 14.54
Chemed (CHE) United States $8.026B 25.23
Elanco Animal Health (ELAN) United States $6.685B 14.32
Option Care Health (OPCH) United States $5.163B 23.01
RadNet (RDNT) United States $4.144B 263.00
Amedisys (AMED) United States $3.199B 21.51
Addus HomeCare (ADUS) United States $2.094B 22.99
LifeStance Health (LFST) United States $1.878B 0.00
Astrana Health (ASTH) United States $1.345B 33.33
U.S Physical Therapy (USPH) United States $1.128B 29.13
Pennant (PNTG) United States $0.958B 35.16
Aveanna Healthcare Holdings (AVAH) United States $0.921B 52.44
Atai Life Sciences (ATAI) Germany $0.497B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.042B 0.00
Ontrak (OTRK) United States $0.006B 0.00
Psychemedics (PMD) United States $0.000B 0.00